Oxford Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-26,913
Closed -$477K 667
2019
Q4
$477K Sell
26,913
-150,876
-85% -$2.61M 0.01% 1251
2019
Q3
$2.76M Sell
177,789
-92,669
-34% -$1.53M 0.07% 372
2019
Q2
$4.65M Buy
270,458
+195,674
+262% +$3.16M 0.1% 257
2019
Q1
$1.2M Buy
74,784
+14,670
+24% +$238K 0.03% 837
2018
Q4
$879K Sell
60,114
-192,954
-76% -$3.08M 0.02% 929
2018
Q3
$4.59M Buy
253,068
+130,948
+107% +$2.29M 0.1% 247
2018
Q2
$2.07M Buy
122,120
+53,518
+78% +$1.01M 0.04% 646
2018
Q1
$1.34M Buy
+68,602
New +$1.33M 0.03% 787
2017
Q2
Sell
-55,863
Closed -$724K 1560
2017
Q1
$724K Sell
55,863
-121,448
-68% -$1.54M 0.02% 931
2016
Q4
$1.75M Buy
+177,311
New +$1.94M 0.06% 359
2016
Q3
Sell
-416,512
Closed -$3.59M 803
2016
Q2
$3.59M Sell
416,512
-13,964
-3% -$138K 0.12% 233
2016
Q1
$4.08M Buy
430,476
+407,385
+1,764% +$3.83M 0.12% 210
2015
Q4
$403K Sell
23,091
-157,799
-87% -$2.52M 0.01% 706
2015
Q3
$2.43M Buy
180,890
+32,192
+22% +$646K 0.08% 262
2015
Q2
$3.36M Sell
148,698
-155,241
-51% -$2.73M 0.09% 246
2015
Q1
$4.34M Buy
303,939
+93,536
+44% +$1.35M 0.11% 215
2014
Q4
$1.98M Sell
210,403
-180,670
-46% -$1.61M 0.04% 385
2014
Q3
$3.6M Buy
391,073
+54,838
+16% +$522K 0.08% 246
2014
Q2
$3.32M Sell
336,235
-120,812
-26% -$1.02M 0.11% 271
2014
Q1
$5.8M Buy
+457,047
New +$6.78M 0.17% 194
2013
Q3
Sell
-74,461
Closed -$591K 841
2013
Q2
$591K Buy
+74,461
New +$474K 0.02% 671

Other funds holding HALO

Oxford Asset Management's HALO Position: Q1 2020 in Review

Oxford Asset Management sold out of Halozyme (HALO) in Q1 2020, closing a stake of 26,913 shares — an estimated $477K sold.

Oxford Asset Management first reported a position in HALO in Q2 2013 and held it in 21 quarters. The position peaked at $5.8M in Q1 2014. 209 funds tracked by Wall St. Rank hold HALO as of Q1 2020.

  • Oxford Asset Management reported no remaining Halozyme position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 26,913 Halozyme shares in Q1 2020, an estimated $477K.
  • Oxford Asset Management first reported a position in Halozyme in Q2 2013 and held it in 21 quarters.
  • Oxford Asset Management's Halozyme position peaked at $5.8M in Q1 2014.
  • 209 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.